Luteinizing Hormone
In clinical developmentAlso known as Gonadotropin, luteinizing hormone, Humegon, ICSH, LH+11 more
Gonadotropin, luteinizing hormone, Humegon, ICSH, LH, Luteinizing gonadotropic hormone, Luteotropic hormone, Luteotropin, Lutropin, Menopur, Pergonal, Pituitary interstitial cell stimulating hormone, Pituitary luteinising hormone, Pituitary luteinizing hormone, Pluset, Luteinising hormone.
Recent clinical, regulatory, research and industry developments relating to this drug.
The role of luteinizing hormone activity in spermatogenesis: from physiology to clinical practice.
Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Testicular Macrophage Trem2
Metabolic control of luteinizing hormone-responsive ovarian steroidogenesis.
Pregnancy Rate by HCG Administration Versus Urinary LH Surge Method in Patients Undergoing IUI
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Andrology1
- Annals of internal medicine1
- eLife1
- Frontiers in endocrinology1
- Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology1
- International journal of molecular sciences1
- Adams RJ1
- Aiznkot T1
- Antonio L1
- Bai H1
- Ballantyne CM1
- Bauer DC1
- Bhasin S1
- Bhinderwala F1
- School of Medicine4
- Department of Clinical Medicine2
- Adelaide Institute for Sleep Health1
- Andrology and Human Reproduction Clinic1
- ANZAC Research Institute1
- Australian Institute of Family Studies1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 8 of the same disease areas as Luteinizing Hormone in the shared literature.
Studied across 7 of the same disease areas as Luteinizing Hormone in the shared literature.
Studied across 6 of the same disease areas as Luteinizing Hormone in the shared literature.
Studied across 6 of the same disease areas as Luteinizing Hormone in the shared literature.
Studied across 4 of the same disease areas as Luteinizing Hormone in the shared literature.
Studied across 5 of the same disease areas as Luteinizing Hormone in the shared literature.
Studied across 3 of the same disease areas as Luteinizing Hormone in the shared literature.
Studied across 2 of the same disease areas as Luteinizing Hormone in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials